Spade Therapeutics

Spade Therapeutics
Drug discovery and development company using a novel technological approach.
About
What does Spade Therapeutics do?
Spade Therapeutics is an ambitious group of entrepreneurs and scientists focused on a different approach to drug discovery and development. They believe that nuanced thinking and a technological edge will lead to new, effective, and safe treatments for patients worldwide.
What is Spade Therapeutics's revenue?
StartupHub estimates Spade Therapeutics's annual revenue at $11.1M (range $2.7M to $17.0M, 27% confidence), based on comparable companies in the sector.
What is Spade Therapeutics's valuation?
StartupHub estimates Spade Therapeutics's effective valuation at $144.4M (range $100.0M to $240.0M, 21% confidence), based on comparable companies in the sector.
How much funding has Spade Therapeutics raised?
Spade Therapeutics has raised a total of $40M in funding. The most recent round on record is Series B.
Where is Spade Therapeutics headquartered?
Spade Therapeutics is headquartered in Cambridge, United States.
When was Spade Therapeutics founded?
Spade Therapeutics was founded in 2022.
What industry does Spade Therapeutics operate in?
Spade Therapeutics operates in Life Sciences, Drug Discovery, Drug Development, Biotech, HealthTech, AI-Driven Drug Discovery.
What is Spade Therapeutics's current status?
Spade Therapeutics's current operating status is: Inactive.
No comments yet. Be the first to share your take.